Use of an indolic compound with nucleophilic substituents at C3 and the dimeric variants thereof in the production of a pharmaceutical composition that can be used in the treatment of B lymphoid neoplasms

Abstract

[EN] The invention relates to the use of an indolic compound with nucleophilic substituents at C3 and the dimeric variants thereof, which exhibit activity against B lymphoid neoplasms selected from chronic lymphatic leukaemia, small B cell lymphoma, and B and Hodgkin lymphomas dependent on infection by the Epstein-barr herpesvirus, and which are used in the production of a pharmaceutical composition that can be used in the treatment of said pathologies.

[ES] La presente invención se refiere al uso de un compuesto indólico con sustituyentes nucleofílicos en el C3 y sus variantes diméricas, que presentan actividad contra neoplasias linfoides B seleccionadas de entre leucemia linfática crónica/linfoma de células B pequeñas, y linfomas B y de Hodgkin dependientes de infección por el herpesvirus de Epstein-Barr y que se utilizan en la preparación de una composición farmacéutica, que presenta utilidad para el tratamiento de dichas patologías.